Trait centric view

1. Trait name:	Milk protein yield
   Ontology terms:	VT:1000165, LPT:0010028, CMO:0000796

   455 genes are associated with this trait, with QTL/association found

   • AAAS: Aladin WD repeat nucleoporin
     evidenced by: QTL:176212;
   • ABCC9: ATP binding cassette subfamily C member 9
     evidenced by: QTL:214814;
   • ABCG2: ATP-binding cassette, sub-family G (WHITE), member 2
     evidenced by: QTL:10488;
   • ACACB: Acetyl-CoA carboxylase beta
     evidenced by: QTL:153263; QTL:153267; QTL:153270; QTL:153275; QTL:153279; QTL:153282; QTL:153290; QTL:153293; QTL:153297; QTL:153301; QTL:153305; QTL:153312; QTL:153316; QTL:153319; QTL:153323; QTL:153326; QTL:153330; QTL:153333; QTL:153340; QTL:153341; QTL:153345; QTL:153348; QTL:153351; QTL:153354; QTL:153357; QTL:153360; QTL:153363; QTL:153366; QTL:153372; QTL:153375; QTL:153377; QTL:153380; QTL:153382; QTL:153387; QTL:153392; QTL:153393; QTL:153396; QTL:153399; QTL:153403; QTL:153409; QTL:153413; QTL:153417; QTL:153421; QTL:153425; QTL:153427;
   • ACADVL: Acyl-CoA dehydrogenase very long chain
     evidenced by: QTL:282759; QTL:282762; QTL:282766; QTL:282768; QTL:282772; QTL:282777; QTL:282781; QTL:282784; QTL:282788; QTL:282792; QTL:282795; QTL:282798; QTL:282801; QTL:282805;
   • ACO2: Aconitase 2, mitochondrial
     evidenced by: QTL:176213;
   • ADAM12: ADAM metallopeptidase domain 12
     evidenced by: QTL:36321;
   • ADAM2: ADAM metallopeptidase domain 2
     evidenced by: QTL:53543;
   • ADGRB1: Adhesion G protein-coupled receptor B1
     evidenced by: QTL:175544; QTL:175545; QTL:175546; QTL:175547;
   • ADGRL3: Adhesion G protein-coupled receptor L3
     evidenced by: QTL:175420; QTL:175421;
   • AFF2: AF4/FMR2 family member 2
     evidenced by: QTL:54502;
   • AGBL4: ATP/GTP binding protein like 4
     evidenced by: QTL:176203;
   • AGO2: Argonaute 2, RISC catalytic component
     evidenced by: QTL:175567; QTL:175568;
   • ALDH18A1: Aldehyde dehydrogenase 18 family member A1
     evidenced by: QTL:261675; QTL:261678; QTL:261681; QTL:261683; QTL:261686; QTL:261687; QTL:261692; QTL:261696; QTL:261700; QTL:261712; QTL:261715; QTL:261718;
   • ALDH5A1: Aldehyde dehydrogenase 5 family member A1
     evidenced by: QTL:52236;
   • ALKBH2: AlkB homolog 2, alpha-ketoglutarate dependent dioxygenase
     evidenced by: QTL:49407;
   • ANCR: Angelman syndrome chromosome region
     evidenced by: QTL:9979;
   • ANK1: Ankyrin 1, erythrocytic
     evidenced by: QTL:156700; QTL:168302;
   • ANKFN1: Ankyrin repeat and fibronectin type III domain containing 1
     evidenced by: QTL:50016;
   • ANKRD17: Ankyrin repeat domain 17
     evidenced by: QTL:42319;
   • ANKRD44: Ankyrin repeat domain 44
     evidenced by: QTL:168273;
   • ANKRD54: Ankyrin repeat domain 54
     evidenced by: QTL:175406;
   • ANO6: Anoctamin 6
     evidenced by: QTL:175373; QTL:176214;
   • APBB2: Amyloid beta precursor protein binding family B member 2
     evidenced by: QTL:42051;
   • APLF: Aprataxin and PNKP like factor
     evidenced by: QTL:45508;
   • APP: Amyloid beta precursor protein
     evidenced by: QTL:38157;
   • ARF3: ADP ribosylation factor 3
     evidenced by: QTL:175367;
   • ARHGAP22: Rho GTPase activating protein 22
     evidenced by: QTL:53856;
   • ARHGAP26: Rho GTPase activating protein 26
     evidenced by: QTL:43066; QTL:43085;
   • ARHGAP39: Rho GTPase activating protein 39
     evidenced by: QTL:175502;
   • ARHGAP6: Rho GTPase activating protein 6
     evidenced by: QTL:55463;
   • ARHGEF12: Rho guanine nucleotide exchange factor 12
     evidenced by: QTL:47855;
   • ARHGEF28: Rho guanine nucleotide exchange factor 28
     evidenced by: QTL:214851;
   • ARID5B: AT rich interactive domain 5B (MRF1-like)
     evidenced by: QTL:16204;
   • ARNTL: Aryl hydrocarbon receptor nuclear translocator like
     evidenced by: QTL:256250; QTL:256251; QTL:256255; QTL:256259; QTL:256285; QTL:256289;
   • ARSG: Arylsulfatase G
     evidenced by: QTL:50254;
   • ASB5: Ankyrin repeat and SOCS box containing 5
     evidenced by: QTL:53323;
   • ATF3: Activating transcription factor 3
     evidenced by: QTL:135466; QTL:135469; QTL:135472; QTL:135476; QTL:135480; QTL:135483; QTL:135486; QTL:135489; QTL:135493; QTL:135497; QTL:135500; QTL:135504; QTL:135509; QTL:135510; QTL:135513; QTL:135516; QTL:135519; QTL:135524; QTL:135527; QTL:135530; QTL:135533; QTL:135537; QTL:135541; QTL:135545; QTL:135549; QTL:135552; QTL:135555; QTL:135582; QTL:135587;
   • ATF6B: Activating transcription factor 6 beta
     evidenced by: QTL:175643;
   • ATF7: Activating transcription factor 7
     evidenced by: QTL:176215;
   • ATP5MC2: ATP synthase membrane subunit c locus 2
     evidenced by: QTL:176216;
   • ATP6V0A4: ATPase, H+ transporting, lysosomal V0 subunit a4
     evidenced by: QTL:168275;
   • AURKA: Aurora kinase A
     evidenced by: QTL:47320;
   • AURKB: Aurora kinase B
     evidenced by: QTL:215094;
   • AVP: Arginine vasopressin
     evidenced by: QTL:57265;
   • B4GALNT3: Beta-1,4-N-acetyl-galactosaminyltransferase 3
     evidenced by: QTL:176217;
   • BAG2: BAG cochaperone 2
     evidenced by: QTL:51928;
   • BCAR3: BCAR3 adaptor protein, NSP family member
     evidenced by: QTL:175338;
   • BCAT1: Branched chain amino-acid transaminase 1, cytosolic
     evidenced by: QTL:16167;
   • BEST3: Bestrophin 3
     evidenced by: QTL:175389; QTL:40915;
   • BICRAL: BRD4 interacting chromatin remodeling complex associated protein like
     evidenced by: QTL:176307;
   • BOP1: Block of proliferation 1
     evidenced by: QTL:156688; QTL:168290;
   • C16H1ORF105: Chromosome 16 C1orf105 homolog
     evidenced by: QTL:175622;
   • C18H19ORF47: Chromosome 18 C19orf47 homolog
     evidenced by: QTL:49670;
   • C5H12ORF40: Chromosome 5 C12orf40 homolog
     evidenced by: QTL:175379;
   • CA8: Carbonic anhydrase VIII
     evidenced by: QTL:18863;
   • CACNA2D3: Calcium voltage-gated channel auxiliary subunit alpha2delta 3
     evidenced by: QTL:176303; QTL:176304;
   • CACNG5: Calcium voltage-gated channel auxiliary subunit gamma 5
     evidenced by: QTL:50275;
   • CACUL1: CDK2 associated cullin domain 1
     evidenced by: QTL:175676;
   • CADPS2: Calcium dependent secretion activator 2
     evidenced by: QTL:40629;
   • CARMIL1: Capping protein regulator and myosin 1 linker 1
     evidenced by: QTL:175669;
   • CAST: Calpastatin
     evidenced by: QTL:57266;
   • CBX6: Chromobox 6
     evidenced by: QTL:176218;
   • CCDC18: Coiled-coil domain containing 18
     evidenced by: QTL:175339;
   • CCDC60: Coiled-coil domain containing 60
     evidenced by: QTL:261860;
   • CCDC69: Coiled-coil domain containing 69
     evidenced by: QTL:43219;
   • CCDC91: Coiled-coil domain containing 91
     evidenced by: QTL:41335;
   • CCL2: Chemokine (C-C motif) ligand 2
     evidenced by: QTL:9937; QTL:9946;
   • CCNB1: Cyclin B1
     evidenced by: QTL:16264;
   • CCND3: Cyclin D3
     evidenced by: QTL:16268; QTL:176306;
   • CD14: CD14 molecule
     evidenced by: QTL:14037; QTL:57267;
   • CD27: CD27 molecule
     evidenced by: QTL:24997;
   • CD4: CD4 molecule
     evidenced by: QTL:14138;
   • CDH4: Cadherin 4
     evidenced by: QTL:175493;
   • CDKAL1: CDK5 regulatory subunit associated protein 1 like 1
     evidenced by: QTL:175670;
   • CDKN1A: Cyclin dependent kinase inhibitor 1A
     evidenced by: QTL:135563; QTL:135568; QTL:135571; QTL:135574; QTL:135578; QTL:135592;
   • CENPE: Centromere protein E
     evidenced by: QTL:172734; QTL:172740; QTL:172743; QTL:172761;
   • CHRM3: Cholinergic receptor muscarinic 3
     evidenced by: QTL:53737;
   • CLCA2: Chloride channel accessory 2
     evidenced by: QTL:175356;
   • CNNM2: Cyclin and CBS domain divalent metal cation transport mediator 2
     evidenced by: QTL:176315;
   • CNTN1: Contactin 1
     evidenced by: QTL:176219;
   • CNTN5: Contactin 5
     evidenced by: QTL:47787;
   • COL22A1: Collagen type XXII alpha 1 chain
     evidenced by: QTL:175589; QTL:175590; QTL:175591;
   • COL24A1: Collagen, type XXIV, alpha 1
     evidenced by: QTL:175359; QTL:175360; QTL:175361;
   • COL4A4: Collagen type IV alpha 4 chain
     evidenced by: QTL:39578;
   • COL4A6: Collagen type IV alpha 6 chain
     evidenced by: QTL:54598;
   • CPA5: Carboxypeptidase A5
     evidenced by: QTL:40665;
   • CPNE5: Copine 5
     evidenced by: QTL:175635;
   • CRACR2A: Calcium release activated channel regulator 2A
     evidenced by: QTL:176220;
   • CSAD: Cysteine sulfinic acid decarboxylase
     evidenced by: QTL:176221; QTL:40834;
   • CSGALNACT1: Chondroitin sulfate N-acetylgalactosaminyltransferase 1
     evidenced by: QTL:53595;
   • CSN1S1: Casein alpha s1
     evidenced by: QTL:3856;
   • CSN2: Casein beta
     evidenced by: QTL:10472; QTL:13559; QTL:136202; QTL:214825; QTL:24995; QTL:31639; QTL:31642; QTL:36283;
   • CSN3: Casein kappa
     evidenced by: QTL:13568; QTL:136216; QTL:136221;
   • CSNK1A1: Casein kinase 1 alpha 1
     evidenced by: QTL:176288;
   • CTBP2: C-terminal binding protein 2
     evidenced by: QTL:125147;
   • CTNNA3: Catenin alpha 3
     evidenced by: QTL:53767;
   • CUL3: Cullin 3
     evidenced by: QTL:39546;
   • CXCR1: Chemokine (C-X-C motif) receptor 1
     evidenced by: QTL:31622;
   • CXCR2: C-X-C motif chemokine receptor 2
     evidenced by: QTL:263443;
   • CYHR1: Cysteine and histidine rich 1
     evidenced by: QTL:175504;
   • CYP21: Cytochrome P450, subfamily XXI (steroid 21-hydroxylase)
     evidenced by: QTL:3631;
   • CYP27A1: Cytochrome P450, family 27, subfamily A, polypeptide 1
     evidenced by: QTL:16147;
   • CYP7A1: Cytochrome P450, family 7, subfamily A, polypeptide 1
     evidenced by: QTL:296705; QTL:296674; QTL:296677; QTL:296680; QTL:296683; QTL:296686; QTL:296708; QTL:296711; QTL:296714;
   • CYP7B1: Cytochrome P450, family 7, subfamily B, polypeptide 1
     evidenced by: QTL:18844;
   • DACH1: Dachshund family transcription factor 1
     evidenced by: QTL:46331;
   • DCK: Deoxycytidine kinase
     evidenced by: QTL:175437;
   • DCUN1D1: Defective in cullin neddylation 1 domain containing 1
     evidenced by: QTL:38498;
   • DDIT3: DNA damage inducible transcript 3
     evidenced by: QTL:168868; QTL:168870; QTL:169688;
   • DGAT1: Diacylglycerol O-acyltransferase 1
     evidenced by: QTL:101364; QTL:101367; QTL:101369; QTL:101371; QTL:101373; QTL:10262; QTL:10401; QTL:10406; QTL:10576; QTL:10578; QTL:121761; QTL:121766; QTL:12215; QTL:126970; QTL:126971; QTL:126972; QTL:130542; QTL:175506; QTL:18998; QTL:214756; QTL:214840; QTL:24994; QTL:31660; QTL:31665; QTL:3509; QTL:3514; QTL:36320; QTL:4583;
   • DHX32: DEAH-box helicase 32 (putative)
     evidenced by: QTL:53098;
   • DIS3L2: DIS3 like 3'-5' exoribonuclease 2
     evidenced by: QTL:175326;
   • DNAJC12: DnaJ heat shock protein family (Hsp40) member C12
     evidenced by: QTL:125148;
   • DOCK1: Dedicator of cytokinesis 1
     evidenced by: QTL:53117;
   • DOCK5: Dedicator of cytokinesis 5
     evidenced by: QTL:175467; QTL:43690;
   • DOK6: Docking protein 6
     evidenced by: QTL:52288;
   • DPP10: Dipeptidyl peptidase like 10
     evidenced by: QTL:176199;
   • DPYD: Dihydropyrimidine dehydrogenase
     evidenced by: QTL:175333; QTL:175334;
   • DTNB: Dystrobrevin beta
     evidenced by: QTL:45537;
   • DZIP3: DAZ interacting zinc finger protein 3
     evidenced by: QTL:57269;
   • EBF1: EBF transcription factor 1
     evidenced by: QTL:43251;
   • EEF1D: Eukaryotic translation elongation factor 1 delta
     evidenced by: QTL:175524;
   • EGF: Epidermal growth factor
     evidenced by: QTL:41929;
   • EIF2B3: Eukaryotic translation initiation factor 2B subunit gamma
     evidenced by: QTL:40191;
   • EMX2: Empty spiracles homeobox 2
     evidenced by: QTL:175673;
   • ENO4: Enolase 4
     evidenced by: QTL:175672;
   • ENTHD1: ENTH domain containing 1
     evidenced by: QTL:41610;
   • EPB41L2: Erythrocyte membrane protein band 4.1 like 2
     evidenced by: QTL:44102;
   • EPPK1: Epiplakin 1
     evidenced by: QTL:175517;
   • ERBB2: Erb-b2 receptor tyrosine kinase 2
     evidenced by: QTL:167461; QTL:167466; QTL:167477;
   • ERC1: ELKS/RAB6-interacting/CAST family member 1
     evidenced by: QTL:176222; QTL:176223; QTL:176224; QTL:176225; QTL:176226;
   • ERC2: ELKS/RAB6-interacting/CAST family member 2
     evidenced by: QTL:176305;
   • ETV1: ETS variant 1
     evidenced by: QTL:125816;
   • EXOC4: Exocyst complex component 4
     evidenced by: QTL:40677;
   • EXT1: Exostosin glycosyltransferase 1
     evidenced by: QTL:47623;
   • FA2H: Fatty acid 2-hydroxylase
     evidenced by: QTL:49444;
   • FABP4: Fatty acid binding protein 4, adipocyte
     evidenced by: QTL:102209; QTL:136245;
   • FADS2: Fatty acid desaturase 2
     evidenced by: QTL:256852; QTL:256856; QTL:256861; QTL:256862; QTL:256866; QTL:256870; QTL:256876; QTL:256877; QTL:256881; QTL:256885; QTL:256886; QTL:256893; QTL:256894; QTL:256902; QTL:256903; QTL:256909; QTL:256910; QTL:256916; QTL:256917; QTL:256922; QTL:256925; QTL:256929; QTL:256934;
   • FAM134B: Family with sequence similarity 134 member B
     evidenced by: QTL:50914;
   • FAM135B: Family with sequence similarity 135 member B
     evidenced by: QTL:175593; QTL:175594; QTL:175595; QTL:175596; QTL:175597;
   • FANK1: Fibronectin type III and ankyrin repeat domains 1
     evidenced by: QTL:175679;
   • FASN: Fatty acid synthase
     evidenced by: QTL:28091; QTL:28096;
   • FBLN5: Fibulin 5
     evidenced by: QTL:51396;
   • FCGR2: Fc fragment of IgG, low affinity IIb, receptor (CD32)
     evidenced by: QTL:172727;
   • FHIT: Fragile histidine triad diadenosine triphosphatase
     evidenced by: QTL:51739;
   • FNDC3B: Fibronectin type III domain containing 3B
     evidenced by: QTL:261857; QTL:38639;
   • FOXA3: Forkhead box A3
     evidenced by: QTL:125142;
   • FRMD5: FERM domain containing 5
     evidenced by: QTL:51349;
   • FRS2: Fibroblast growth factor receptor substrate 2
     evidenced by: QTL:175390;
   • FST: Follistatin
     evidenced by: QTL:57270;
   • FUT10: Fucosyltransferase 10
     evidenced by: QTL:53470;
   • GABARAPL1: GABA(A) receptor-associated protein like 1
     evidenced by: QTL:16172;
   • GABBR1: Gamma-aminobutyric acid type B receptor subunit 1
     evidenced by: QTL:175653;
   • GABBR2: Gamma-aminobutyric acid type B receptor subunit 2
     evidenced by: QTL:175466;
   • GALE: UDP-galactose-4-epimerase
     evidenced by: QTL:263418; QTL:263422; QTL:263426; QTL:263430;
   • GALNT8: Polypeptide N-acetylgalactosaminyltransferase 8
     evidenced by: QTL:175399;
   • GC: Group-specific component (vitamin D binding protein)
     evidenced by: QTL:175444; QTL:176283;
   • GCNT3: Glucosaminyl (N-acetyl) transferase 3, mucin type
     evidenced by: QTL:57271;
   • GFRA2: GDNF family receptor alpha 2
     evidenced by: QTL:223348;
   • GH1: Growth hormone 1
     evidenced by: QTL:10220; QTL:14081; QTL:19059; QTL:136262;
   • GHR: Growth hormone receptor
     evidenced by: QTL:12877; QTL:12878; QTL:12879; QTL:12880; QTL:12881; QTL:12966; QTL:12967; QTL:12968;
   • GLYCAM1: Glycosylation-dependent cell adhesion molecule 1
     evidenced by: QTL:176227;
   • GML: Glycosylphosphatidylinositol anchored molecule like
     evidenced by: QTL:175535; QTL:175536;
   • GNAS: GNAS complex locus
     evidenced by: QTL:16137;
   • GPM6B: Glycoprotein M6B
     evidenced by: QTL:55444;
   • GPR20: G protein-coupled receptor 20
     evidenced by: QTL:175559;
   • GRB10: Growth factor receptor-bound protein 10
     evidenced by: QTL:13516;
   • GRIN3A: Glutamate ionotropic receptor NMDA type subunit 3A
     evidenced by: QTL:156681; QTL:168284;
   • GRK5: G protein-coupled receptor kinase 5
     evidenced by: QTL:175678;
   • GSK3A: Glycogen synthase kinase 3 alpha
     evidenced by: QTL:49688;
   • GSTA3: Glutathione S-transferase, alpha 3
     evidenced by: QTL:175637;
   • GYS2: Glycogen synthase 2
     evidenced by: QTL:214730;
   • HADHB: Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
     evidenced by: QTL:296689; QTL:296692; QTL:296694; QTL:296697; QTL:296699; QTL:296702; QTL:296716; QTL:296719;
   • HCN1: Hyperpolarization activated cyclic nucleotide gated potassium channel 1
     evidenced by: QTL:176296;
   • HERC6: Hect domain and RLD 6
     evidenced by: QTL:10492;
   • HHAT: Hedgehog acyltransferase
     evidenced by: QTL:48487;
   • HMGA2: High mobility group AT-hook 2
     evidenced by: QTL:176228;
   • HOXC8: Homeobox C8
     evidenced by: QTL:176229;
   • HPCAL1: Hippocalcin like 1
     evidenced by: QTL:45968; QTL:45980;
   • HPSE2: Heparanase 2 (inactive)
     evidenced by: QTL:52756; QTL:52767; QTL:52780;
   • HSD17B7: Hydroxysteroid (17-beta) dehydrogenase 7
     evidenced by: QTL:57272;
   • HSPA12A: Heat shock 70kDa protein 12A
     evidenced by: QTL:175671;
   • HSPA8: Heat shock protein family A (Hsp70) member 8
     evidenced by: QTL:167453; QTL:167457;
   • IDH1: Isocitrate dehydrogenase 1 (NADP+), soluble
     evidenced by: QTL:16153;
   • IDH2: Isocitrate dehydrogenase (NADP(+)) 2
     evidenced by: QTL:315653; QTL:315654; QTL:315658; QTL:315659; QTL:315665; QTL:315666; QTL:315673; QTL:315674; QTL:315679; QTL:315699;
   • IFIH1: Interferon induced with helicase C domain 1
     evidenced by: QTL:16212;
   • IGF1: Insulin-like growth factor 1 (somatomedin C)
     evidenced by: QTL:13038; QTL:19051; QTL:20619;
   • IGF1R: Insulin-like growth factor 1 receptor
     evidenced by: QTL:122168; QTL:122169; QTL:122170; QTL:122171; QTL:122172; QTL:122173; QTL:122174; QTL:122175; QTL:122176; QTL:122177; QTL:122199; QTL:122200; QTL:122201; QTL:122202; QTL:122203; QTL:122204; QTL:122205; QTL:122206; QTL:122207; QTL:122208; QTL:122230; QTL:122231; QTL:122232; QTL:122233; QTL:122234; QTL:122235; QTL:122236;
   • IGF2: Insulin-like growth factor 2 (somatomedin A)
     evidenced by: QTL:12409; QTL:13045; QTL:13046;
   • IL12RB2: Interleukin 12 receptor, beta 2
     evidenced by: QTL:13224; QTL:13225; QTL:13226;
   • IL1RAPL2: Interleukin 1 receptor accessory protein-like 2
     evidenced by: QTL:54540;
   • IL8: Interleukin 8
     evidenced by: QTL:15949; QTL:263440;
   • IQANK1: IQ motif and ankyrin repeat containing 1
     evidenced by: QTL:175521;
   • IQSEC3: IQ motif and Sec7 domain 3
     evidenced by: QTL:176230;
   • IRF6: Interferon regulatory factor 6
     evidenced by: QTL:282810; QTL:282813; QTL:282816; QTL:282819; QTL:282824; QTL:282827; QTL:282831; QTL:282834; QTL:282839; QTL:282842; QTL:282847; QTL:282850; QTL:282855; QTL:282859; QTL:282864;
   • IRF9: Interferon regulatory factor 9
     evidenced by: QTL:16244;
   • ITGA1: Integrin subunit alpha 1
     evidenced by: QTL:176297; QTL:176298;
   • ITGB1BP1: Integrin subunit beta 1 binding protein 1
     evidenced by: QTL:46034;
   • ITPK1: Inositol-tetrakisphosphate 1-kinase
     evidenced by: QTL:51428;
   • KCNA6: Potassium voltage-gated channel subfamily A member 6
     evidenced by: QTL:175397;
   • KCNIP4: Kv channel interacting protein 4
     evidenced by: QTL:41972;
   • KCNK9: Potassium two pore domain channel subfamily K member 9
     evidenced by: QTL:175577; QTL:175578;
   • KCNT1: Potassium sodium-activated channel subfamily T member 1
     evidenced by: QTL:46123;
   • KDM4C: Lysine demethylase 4C
     evidenced by: QTL:43620; QTL:43629; QTL:43638;
   • KHDRBS3: KH domain containing, RNA binding, signal transduction associated 3
     evidenced by: QTL:175607; QTL:175608;
   • KLF6: KLF transcription factor 6
     evidenced by: QTL:314331; QTL:314336; QTL:314340; QTL:314345; QTL:314348; QTL:314353; QTL:314355; QTL:314358; QTL:314360; QTL:314362; QTL:314366; QTL:314371; QTL:314374; QTL:314379; QTL:314384; QTL:314388; QTL:314392; QTL:314396; QTL:314401; QTL:314406; QTL:314409; QTL:314413; QTL:314417; QTL:314422;
   • KMT2A: Lysine methyltransferase 2A
     evidenced by: QTL:47845;
   • KSR2: Kinase suppressor of ras 2
     evidenced by: QTL:16249;
   • LALBA: Lactalbumin, alpha-
     evidenced by: QTL:238153;
   • LAP3: Leucine aminopeptidase 3
     evidenced by: QTL:10477;
   • LARP4B: La ribonucleoprotein domain family member 4B
     evidenced by: QTL:168840;
   • LDHA: Lactate dehydrogenase A
     evidenced by: QTL:315683;
   • LDHB: Lactate dehydrogenase B
     evidenced by: QTL:315690;
   • LEP: Leptin
     evidenced by: QTL:13024; QTL:31173; QTL:31625; QTL:31629;
   • LETM1: Leucine zipper and EF-hand containing transmembrane protein 1
     evidenced by: QTL:42561;
   • LIN7A: Lin-7 homolog A, crumbs cell polarity complex component
     evidenced by: QTL:40742; QTL:40760;
   • LIPT2: Lipoyl(octanoyl) transferase 2
     evidenced by: QTL:47917;
   • LOC100140490: Transmembrane protease serine 11C
     evidenced by: QTL:175429;
   • LOC100140503: Alpha-fetoprotein-like
     evidenced by: QTL:175455;
   • LOC100848939: Uncharacterized LOC100848939
     evidenced by: QTL:175539;
   • LOC101901918: Uncharacterized LOC101901918
     evidenced by: QTL:175552;
   • LOC101905166: Uncharacterized LOC101905166
     evidenced by: QTL:175408;
   • LOC104968898: Uncharacterized LOC104968898
     evidenced by: QTL:175457; QTL:175458;
   • LOC104973254: Uncharacterized LOC104973254
     evidenced by: QTL:175491;
   • LOC107132524: Uncharacterized LOC107132524
     evidenced by: QTL:176233;
   • LOC615278: E3 ubiquitin-protein ligase TRIM39
     evidenced by: QTL:175647; QTL:175648; QTL:175649;
   • LOC617565: C-type lectin domain family 2 member D11
     evidenced by: QTL:176234;
   • LOC781710: Guanylate-binding protein 2
     evidenced by: QTL:175349;
   • LOC786372: Golgin subfamily A member 6-like protein 22
     evidenced by: QTL:175348;
   • LOC786706: Butyrophilin subfamily 1 member A1-like
     evidenced by: QTL:175668;
   • LOC786987: Protein C19orf12 homolog
     evidenced by: QTL:175654;
   • LOC787628: Cytochrome P450 11B1, mitochondrial
     evidenced by: QTL:175534;
   • LPHN2: Latrophilin 2
     evidenced by: QTL:175362; QTL:175363;
   • LPIN1: Lipin 1
     evidenced by: QTL:170541; QTL:170545; QTL:170547; QTL:170549; QTL:170554; QTL:170557; QTL:170560; QTL:170564; QTL:170569; QTL:170573; QTL:170575;
   • LRRC8D: Leucine rich repeat containing 8 VRAC subunit D
     evidenced by: QTL:175346;
   • LTF: Lactotransferrin
     evidenced by: QTL:11617;
   • LY6E: Lymphocyte antigen 6 family member E
     evidenced by: QTL:175532;
   • MACROD2: MACRO domain containing 2
     evidenced by: QTL:43700;
   • MAF1: MAF1 homolog, negative regulator of RNA polymerase III
     evidenced by: QTL:175510;
   • MAGI1: Membrane associated guanylate kinase, WW and PDZ domain containing 1
     evidenced by: QTL:51651;
   • MAML3: Mastermind like transcriptional coactivator 3
     evidenced by: QTL:48979;
   • MAOB: Monoamine oxidase B
     evidenced by: QTL:54921;
   • MAPK15: Mitogen-activated protein kinase 15
     evidenced by: QTL:175522;
   • MAT2A: Methionine adenosyltransferase 2A
     evidenced by: QTL:261705; QTL:261709;
   • MBNL3: Muscleblind like splicing regulator 3
     evidenced by: QTL:54321;
   • MCM8: Minichromosome maintenance 8 homologous recombination repair factor
     evidenced by: QTL:47130;
   • MED28: Mediator complex subunit 28
     evidenced by: QTL:10474;
   • MEGF6: Multiple EGF like domains 6
     evidenced by: QTL:175630;
   • MICALL1: MICAL like 1
     evidenced by: QTL:175407;
   • MOCS1: Molybdenum cofactor synthesis 1
     evidenced by: QTL:176308; QTL:52012;
   • MOXD1: Monooxygenase DBH like 1
     evidenced by: QTL:175470;
   • MROH1: Maestro heat-like repeat family member 1
     evidenced by: QTL:175507; QTL:175508; QTL:175509;
   • MRPS27: Mitochondrial ribosomal protein S27
     evidenced by: QTL:156696;
   • MRPS28: Mitochondrial ribosomal protein S28
     evidenced by: QTL:176292;
   • MSH5: MutS homolog 5
     evidenced by: QTL:175644;
   • MSTN: Myostatin
     evidenced by: QTL:18825;
   • MTF2: Metal response element binding transcription factor 2
     evidenced by: QTL:175340;
   • MTMR3: Myotubularin related protein 3
     evidenced by: QTL:16186;
   • MYBPC1: Myosin binding protein C, slow type
     evidenced by: QTL:40989;
   • NALCN: Sodium leak channel, non-selective
     evidenced by: QTL:46539;
   • NARS2: Asparaginyl-tRNA synthetase 2, mitochondrial
     evidenced by: QTL:156701; QTL:168303;
   • NBAS: NBAS subunit of NRZ tethering complex
     evidenced by: QTL:45729;
   • NCKAP1L: NCK associated protein 1 like
     evidenced by: QTL:176235;
   • NCKAP5: NCK-associated protein 5
     evidenced by: QTL:176200;
   • NCR3: Natural cytotoxicity triggering receptor 3
     evidenced by: QTL:175645;
   • NCSTN: Nicastrin
     evidenced by: QTL:39721;
   • NDRG4: NDRG family member 4
     evidenced by: QTL:16256;
   • NDUFA9: NADH:ubiquinone oxidoreductase subunit A9
     evidenced by: QTL:175400;
   • NELL2: Neural EGFL like 2
     evidenced by: QTL:175374; QTL:175375; QTL:176236;
   • NFAM1: NFAT activating protein with ITAM motif 1
     evidenced by: QTL:41680;
   • NFKBIL1: Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1
     evidenced by: QTL:57273;
   • NGFR: Nerve growth factor receptor
     evidenced by: QTL:256240; QTL:256279; QTL:256282;
   • NHSL1: NHS like 1
     evidenced by: QTL:44144;
   • NINJ2: Ninjurin 2
     evidenced by: QTL:176237;
   • NLK: Nemo-like kinase
     evidenced by: QTL:172753; QTL:172754;
   • NLRP9: NLR family, pyrin domain containing 9
     evidenced by: QTL:57274;
   • NOD2: Nucleotide-binding oligomerization domain containing 2
     evidenced by: QTL:9989; QTL:9990;
   • NOTCH4: Notch receptor 4
     evidenced by: QTL:175642;
   • NPC1: Niemann-Pick disease, type C1
     evidenced by: QTL:16273;
   • NPFFR2: Neuropeptide FF receptor 2
     evidenced by: QTL:175451; QTL:175452;
   • NR4A1: Nuclear receptor subfamily 4 group A member 1
     evidenced by: QTL:169026; QTL:169029; QTL:169033; QTL:169037; QTL:169041; QTL:169045; QTL:169048; QTL:169052; QTL:169056; QTL:169059; QTL:169062; QTL:169065; QTL:169069; QTL:169712; QTL:169716; QTL:176238;
   • NRG3: Neuregulin 3
     evidenced by: QTL:53827;
   • NRSN2: Neurensin 2
     evidenced by: QTL:47332;
   • NRXN3: Neurexin 3
     evidenced by: QTL:36317;
   • NSD2: Nuclear receptor binding SET domain protein 2
     evidenced by: QTL:42581;
   • NT5DC3: 5'-nucleotidase domain containing 3
     evidenced by: QTL:176239; QTL:41057;
   • NT5E: 5'-nucleotidase, ecto (CD73)
     evidenced by: QTL:44084;
   • NTM: Neurotrimin
     evidenced by: QTL:156702; QTL:168304;
   • NUCB2: Nucleobindin 2
     evidenced by: QTL:176533; QTL:176540; QTL:176544; QTL:176550; QTL:176556; QTL:176560; QTL:176565; QTL:176570; QTL:176576; QTL:176582; QTL:176586;
   • OAS1Z: 2',5'-oligoadenylate synthetase 1, 40/46kDa
     evidenced by: QTL:16190;
   • OR12D2: Olfactory receptor, family 12, subfamily D, member 2
     evidenced by: QTL:175657; QTL:175658;
   • PAEP: Progestagen-associated endometrial protein
     evidenced by: QTL:12420; QTL:31649; QTL:31651; QTL:31653;
   • PAK5: P21 (RAC1) activated kinase 5
     evidenced by: QTL:46629;
   • PALLD: Palladin, cytoskeletal associated protein
     evidenced by: QTL:223349;
   • PALMD: Palmdelphin
     evidenced by: QTL:175330;
   • PARM1: Prostate androgen-regulated mucin-like protein 1
     evidenced by: QTL:57275;
   • PARP12: Poly (ADP-ribose) polymerase family, member 12
     evidenced by: QTL:16224;
   • PCBD1: Pterin-4 alpha-carbinolamine dehydratase 1
     evidenced by: QTL:53784;
   • PCDHA13: Protocadherin alpha 13
     evidenced by: QTL:176289; QTL:43050;
   • PCED1B: PC-esterase domain containing 1B
     evidenced by: QTL:176240;
   • PCIF1: Phosphorylated CTD interacting factor 1
     evidenced by: QTL:47376;
   • PDE1B: Phosphodiesterase 1B, calmodulin-dependent
     evidenced by: QTL:176241; QTL:40815;
   • PDE4D: Phosphodiesterase 4D
     evidenced by: QTL:50697; QTL:50717;
   • PDE7B: Phosphodiesterase 7B
     evidenced by: QTL:175478;
   • PDE9A: Phosphodiesterase 9A
     evidenced by: QTL:64787; QTL:64789; QTL:64792; QTL:64793; QTL:64796; QTL:64799; QTL:64802; QTL:64805;
   • PDGFRB: Platelet derived growth factor receptor beta
     evidenced by: QTL:43182;
   • PEA15: Proliferation and apoptosis adaptor protein 15
     evidenced by: QTL:39736;
   • PHF20: PHD finger protein 20
     evidenced by: QTL:47341;
   • PHF2: PHD finger protein 2
     evidenced by: QTL:43723;
   • PHKA2: Phosphorylase kinase regulatory subunit alpha 2
     evidenced by: QTL:55221;
   • PIBF1: Progesterone immunomodulatory binding factor 1
     evidenced by: QTL:46361;
   • PIGN: Phosphatidylinositol glycan anchor biosynthesis class N
     evidenced by: QTL:52450;
   • PITRM1: Pitrilysin metallopeptidase 1
     evidenced by: QTL:47110;
   • PKHD1: PKHD1, fibrocystin/polyductin
     evidenced by: QTL:223347;
   • PKLR: Pyruvate kinase L/R
     evidenced by: QTL:261496; QTL:261532; QTL:261537; QTL:261542; QTL:261548;
   • PLA2G6: Phospholipase A2 group VI
     evidenced by: QTL:175410;
   • PLCB1: Phospholipase C beta 1
     evidenced by: QTL:46614;
   • PLCE1: Phospholipase C, epsilon 1
     evidenced by: QTL:24996;
   • PLEC: Plectin
     evidenced by: QTL:175515;
   • PLPPR5: Phospholipid phosphatase related 5
     evidenced by: QTL:175331;
   • PLXNC1: Plexin C1
     evidenced by: QTL:176242;
   • PMM2: Phosphomannomutase 2
     evidenced by: QTL:57277;
   • POLD1: DNA polymerase delta 1, catalytic subunit
     evidenced by: QTL:156691; QTL:168293;
   • POU6F2: POU class 6 homeobox 2
     evidenced by: QTL:175366;
   • PPARGC1A: Peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
     evidenced by: QTL:20652; QTL:31633;
   • PPM1H: Protein phosphatase, Mg2+/Mn2+ dependent 1H
     evidenced by: QTL:176243;
   • PPP1R16A: Protein phosphatase 1 regulatory subunit 16A
     evidenced by: QTL:175503;
   • PPP2R2B: Protein phosphatase 2 regulatory subunit Bbeta
     evidenced by: QTL:256263; QTL:256266; QTL:256269;
   • PREX1: Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1
     evidenced by: QTL:156687;
   • PRKDC: Protein kinase, DNA-activated, catalytic polypeptide
     evidenced by: QTL:175613; QTL:175614;
   • PRLR: Prolactin receptor
     evidenced by: QTL:121757; QTL:31680;
   • PRMT8: Protein arginine methyltransferase 8
     evidenced by: QTL:176244;
   • PRNP: Prion protein
     evidenced by: QTL:3614; QTL:3615; QTL:1677; QTL:2750; QTL:2465; QTL:2693; QTL:3369; QTL:3410; QTL:1522;
   • PROP1: PROP paired-like homeobox 1
     evidenced by: QTL:25220;
   • PRRX2: Paired related homeobox 2
     evidenced by: QTL:46109;
   • PSMD1: Proteasome 26S subunit, non-ATPase 1
     evidenced by: QTL:175325;
   • PTBP2: Polypyrimidine tract binding protein 2
     evidenced by: QTL:39787;
   • PTK2: Protein tyrosine kinase 2
     evidenced by: QTL:175562; QTL:175563; QTL:71145; QTL:71151; QTL:71196; QTL:71200; QTL:71206; QTL:71209; QTL:71215; QTL:71218; QTL:71221; QTL:71224;
   • PTPRR: Protein tyrosine phosphatase, receptor type R
     evidenced by: QTL:175381; QTL:175382; QTL:175383;
   • PTPRU: Protein tyrosine phosphatase, receptor type U
     evidenced by: QTL:156671; QTL:168272;
   • PUS7L: Pseudouridine synthase 7 like
     evidenced by: QTL:176245;
   • RAB3IP: RAB3A interacting protein
     evidenced by: QTL:175388;
   • RASGRP3: RAS guanyl releasing protein 3
     evidenced by: QTL:45185;
   • RASSF9: Ras association domain family member 9
     evidenced by: QTL:176246;
   • RBM47: RNA binding motif protein 47
     evidenced by: QTL:42038;
   • RETSAT: Retinol saturase
     evidenced by: QTL:172746;
   • RGS22: Regulator of G-protein signaling 22
     evidenced by: QTL:18875;
   • RHPN1: Rhophilin Rho GTPase binding protein 1
     evidenced by: QTL:175527;
   • RNF10: Ring finger protein 10
     evidenced by: QTL:49403;
   • ROBO1: Roundabout, axon guidance receptor, homolog 1 (Drosophila)
     evidenced by: QTL:2500;
   • ROCK2: Rho associated coiled-coil containing protein kinase 2
     evidenced by: QTL:45921;
   • RPL23A: Ribosomal protein L23a
     evidenced by: QTL:168873; QTL:168876; QTL:168881; QTL:168886; QTL:168889; QTL:168893; QTL:168897; QTL:168900; QTL:168903; QTL:168907; QTL:168911; QTL:168919; QTL:168923; QTL:168927; QTL:168930; QTL:168933; QTL:168939; QTL:168942; QTL:168946; QTL:169691; QTL:169695;
   • RUFY3: RUN and FYVE domain containing 3
     evidenced by: QTL:175436;
   • RUNX2: RUNX family transcription factor 2
     evidenced by: QTL:176309;
   • SAA2: Serum amyloid A2
     evidenced by: QTL:138694; QTL:138697; QTL:138699; QTL:138701; QTL:139816; QTL:139819; QTL:139821; QTL:139824; QTL:139825; QTL:64988; QTL:64990; QTL:64993; QTL:64995; QTL:64997;
   • SCD: Stearoyl-CoA desaturase (delta-9-desaturase)
     evidenced by: QTL:11702;
   • SCRIB: Scribbled planar cell polarity protein
     evidenced by: QTL:175520;
   • SCRN1: Secernin 1
     evidenced by: QTL:16229;
   • SEC13: SEC13 homolog, nuclear pore and COPII coat complex component
     evidenced by: QTL:263570; QTL:263573; QTL:263577; QTL:263579; QTL:263582; QTL:263586;
   • SEC22A: SEC22 homolog A, vesicle trafficking protein
     evidenced by: QTL:38465;
   • SEC23IP: SEC23 interacting protein
     evidenced by: QTL:53014;
   • SEC24D: SEC24 homolog D, COPII coat complex component
     evidenced by: QTL:41856;
   • SEC63: SEC63 homolog, protein translocation regulator
     evidenced by: QTL:43970;
   • SECISBP2: SECIS binding protein 2
     evidenced by: QTL:43757;
   • SEL1L: SEL1L ERAD E3 ligase adaptor subunit
     evidenced by: QTL:156684; QTL:168287;
   • SERPINA1: Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
     evidenced by: QTL:136276; QTL:14040;
   • SERPINA5: Serpin family A member 5
     evidenced by: QTL:125144;
   • SERPINB5: Serpin family B member 5
     evidenced by: QTL:52460;
   • SESN2: Sestrin 2
     evidenced by: QTL:168954; QTL:168959; QTL:168961; QTL:168964; QTL:168965; QTL:168971; QTL:168976; QTL:168979; QTL:168991; QTL:168997; QTL:169000; QTL:169003; QTL:169006; QTL:169009; QTL:169013; QTL:169016; QTL:169019; QTL:169022; QTL:169701; QTL:169702; QTL:169707; QTL:169709;
   • SFXN4: Sideroflexin 4
     evidenced by: QTL:52980;
   • SH2D2A: SH2 domain containing 2A
     evidenced by: QTL:39750;
   • SHANK2: SH3 and multiple ankyrin repeat domains 2
     evidenced by: QTL:53978;
   • SHROOM2: Shroom family member 2
     evidenced by: QTL:55637;
   • SLC10A7: Solute carrier family 10 member 7
     evidenced by: QTL:48715;
   • SLC22A7: Solute carrier family 22 member 7
     evidenced by: QTL:256216; QTL:256217; QTL:256220; QTL:256223; QTL:256227; QTL:256228; QTL:256230; QTL:256233; QTL:256274;
   • SLC24A4: Solute carrier family 24 member 4
     evidenced by: QTL:51410;
   • SLC25A21: Solute carrier family 25 member 21
     evidenced by: QTL:51287;
   • SLC2A13: Solute carrier family 2 member 13
     evidenced by: QTL:175378;
   • SLC36A2: Solute carrier family 36 member 2
     evidenced by: QTL:168838; QTL:168839;
   • SLC38A1: Solute carrier family 38, member 1
     evidenced by: QTL:175369;
   • SLC45A4: Solute carrier family 45 member 4
     evidenced by: QTL:175560;
   • SLC4A4: Solute carrier family 4 member 4
     evidenced by: QTL:156676; QTL:168279; QTL:175440; QTL:176284;
   • SLC6A13: Solute carrier family 6 member 13
     evidenced by: QTL:176247; QTL:176248; QTL:176249; QTL:176250;
   • SLC8A1: Solute carrier family 8 (sodium/calcium exchanger), member 1
     evidenced by: QTL:45246; QTL:45255;
   • SLC9A9: Solute carrier family 9 member A9
     evidenced by: QTL:123977;
   • SLCO1A2: Solute carrier organic anion transporter family member 1A2
     evidenced by: QTL:215044; QTL:41452;
   • SLIT3: Slit guidance ligand 3
     evidenced by: QTL:50320;
   • SMPD5: Sphingomyelin phosphodiesterase 5, pseudogene
     evidenced by: QTL:175512;
   • SMYD1: SET and MYND domain containing 1
     evidenced by: QTL:45408;
   • SMYD3: SET and MYND domain containing 3
     evidenced by: QTL:156690; QTL:168292;
   • SOWAHB: Sosondowah ankyrin repeat domain family member B
     evidenced by: QTL:42363;
   • SP140L: SP140 nuclear body protein-like
     evidenced by: QTL:175324;
   • SPATS2: Spermatogenesis associated serine rich 2
     evidenced by: QTL:176251;
   • SPIDR: Scaffold protein involved in DNA repair
     evidenced by: QTL:175612;
   • SPOCK1: SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1
     evidenced by: QTL:43016;
   • SPSB1: SplA/ryanodine receptor domain and SOCS box containing 1
     evidenced by: QTL:175627;
   • SRC: V-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)
     evidenced by: QTL:13150;
   • SREBF2: Sterol regulatory element binding transcription factor 2
     evidenced by: QTL:41623;
   • STAT1: Signal transducer and activator of transcription 1, 91kDa
     evidenced by: QTL:9985;
   • STAT5A: Signal transducer and activator of transcription 5A
     evidenced by: QTL:10271; QTL:136256;
   • STAT5B: Signal transducer and activator of transcription 5B
     evidenced by: QTL:14141;
   • STIM1: Stromal interaction molecule 1
     evidenced by: QTL:175618;
   • STK3: Serine/threonine kinase 3
     evidenced by: QTL:168291;
   • SUCLG2: Succinate-CoA ligase GDP-forming subunit beta
     evidenced by: QTL:51582;
   • SUPT3H: SPT3 homolog, SAGA and STAGA complex component
     evidenced by: QTL:176310;
   • SYN3: Synapsin III
     evidenced by: QTL:41206; QTL:41226;
   • SYT3: Synaptotagmin 3
     evidenced by: QTL:49874;
   • TANK: TRAF family member associated NFKB activator
     evidenced by: QTL:39346;
   • TBC1D12: TBC1 domain family member 12
     evidenced by: QTL:52690;
   • TBC1D9: TBC1 domain family member 9
     evidenced by: QTL:48967;
   • TBCD: Tubulin folding cofactor D
     evidenced by: QTL:50068;
   • TCF19: Transcription factor 19
     evidenced by: QTL:175646;
   • TCF20: Transcription factor 20
     evidenced by: QTL:41666;
   • TCF7L2: Transcription factor 7-like 2 (T-cell specific, HMG-box)
     evidenced by: QTL:10197;
   • TENM2: Teneurin transmembrane protein 2
     evidenced by: QTL:43310;
   • TGM2: Transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)
     evidenced by: QTL:16181;
   • THRSP: Thyroid hormone responsive
     evidenced by: QTL:31689;
   • TMC5: Transmembrane channel like 5
     evidenced by: QTL:52545;
   • TMCC3: Transmembrane and coiled-coil domain family 3
     evidenced by: QTL:176252; QTL:176253; QTL:176254;
   • TMPRSS11F: Transmembrane protease, serine 11F
     evidenced by: QTL:175430;
   • TNFSF10: Tumor necrosis factor (ligand) superfamily, member 10
     evidenced by: QTL:16208;
   • TNIK: TRAF2 and NCK interacting kinase
     evidenced by: QTL:175323;
   • TNS3: Tensin 3
     evidenced by: QTL:175365;
   • TPH1: Tryptophan hydroxylase 1
     evidenced by: QTL:31674;
   • TRAF3IP2: TRAF3 interacting protein 2
     evidenced by: QTL:43958;
   • TRAPPC9: Trafficking protein particle complex 9
     evidenced by: QTL:175570; QTL:175571; QTL:175572; QTL:175573; QTL:175574; QTL:175575; QTL:175576; QTL:47474;
   • TRIM31: Tripartite motif containing 31
     evidenced by: QTL:175651;
   • TRIM56: Tripartite motif containing 56
     evidenced by: QTL:176314;
   • TSNARE1: T-SNARE domain containing 1
     evidenced by: QTL:175548;
   • TSPAN11: Tetraspanin 11
     evidenced by: QTL:176255;
   • TULP3: Tubby like protein 3
     evidenced by: QTL:175404;
   • UBE2E2: Ubiquitin conjugating enzyme E2 E2
     evidenced by: QTL:53609;
   • UBOX5: U-box domain containing 5
     evidenced by: QTL:47174;
   • UBR5: Ubiquitin protein ligase E3 component n-recognin 5
     evidenced by: QTL:18840;
   • UGT2A1: UDP glucuronosyltransferase family 2 member A1 complex locus
     evidenced by: QTL:175432;
   • UHRF2: Ubiquitin like with PHD and ring finger domains 2
     evidenced by: QTL:43644;
   • UMPS: Uridine monophosphate synthetase
     evidenced by: QTL:223350;
   • USP24: Ubiquitin specific peptidase 24
     evidenced by: QTL:176206;
   • VPS28: VPS28, ESCRT-I subunit
     evidenced by: QTL:175505; QTL:47445;
   • VPS35: VPS35 retromer complex component
     evidenced by: QTL:168294;
   • VWA8: Von Willebrand factor A domain containing 8
     evidenced by: QTL:46198;
   • WDR17: WD repeat domain 17
     evidenced by: QTL:53308;
   • WDR62: WD repeat domain 62
     evidenced by: QTL:168844; QTL:168845; QTL:168846; QTL:168847;
   • WWC3: WWC family member 3
     evidenced by: QTL:55581; QTL:55599;
   • ZBP1: Z-DNA binding protein 1
     evidenced by: QTL:47303;
   • ZC3H3: Zinc finger CCCH-type containing 3
     evidenced by: QTL:175525; QTL:175526;
   • ZFAND3: Zinc finger AN1-type containing 3
     evidenced by: QTL:176311;
   • ZFP57: ZFP57 zinc finger protein
     evidenced by: QTL:175652;
   • ZKSCAN4: Zinc finger with KRAB and SCAN domains 4
     evidenced by: QTL:175663;
   • ZKSCAN8: Zinc finger with KRAB and SCAN domains 8
     evidenced by: QTL:52183;
   • ZNF16: Zinc finger protein 16
     evidenced by: QTL:175496; QTL:175497;
   • ZNF335: Zinc finger protein 335
     evidenced by: QTL:47390;
   • ZNF407: Zinc finger protein 407
     evidenced by: QTL:52271;
   • ZNF45: Zinc finger protein 45
     evidenced by: QTL:49799;
   • ZNF696: Zinc finger protein 696
     evidenced by: QTL:175529;
   691 correlations are found involving Milk protein yield
    

2. Trait name:	Milk protein yield persistency
   Ontology terms:	VT:1000165

   1 gene are associated with this trait, with QTL/association found

   • PRNP: Prion protein
     evidenced by: QTL:3415;
   14 correlations are found involving Milk protein yield persistency